Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA. neel_david_a@lilly.com
Abstract:
Syntheses and SAR studies of 3,3-bisaryloxindole analogues provided potent mineralocorticoid receptor (MR) antagonists that were selective over other steroid nuclear hormone receptors.